Metformin
Yes
No
Dear Healthcare Professional Letters
Standard Drug List
Active ingredient: Metformin
General information
Subsidy Information and Financing Scheme
Drug Guidance for Subsidy
18/01/2021 Metformin extended release for treating type 2 diabetes mellitus
[NR] The Ministry of Health’s Drug Advisory Committee has not recommended listing metformin extended release on the Standard Drug List (SDL) for treating type 2 diabetes mellitus because of limited clinical need and unfavourable cost-effectiveness compared with metformin immediate release.
Post Marketing Information
General Availability in Public Healthcare Institution
Note:
General availability information reflected is based on the Public Healthcare Institutions’ (PHI) formulary on what is commonly used for treating their patient population and may or may not be available for patients not under the care of that institution. It does not reflect the PHI’s actual inventory availability and is subjected to change. Please consult the Public Hospitals or Polyclinics for details on availability and supply restrictions/considerations. General availability is not tied to any brand unless otherwise stated.
Users are to consult the respective PHIs for actual inventory availability and supply restrictions/consideration
Availability information
Formulation | Public Healthcare Institution |
|---|---|
Tablet 250 mg |
|
Tablet 500 mg |
|
Tablet 850 mg |
|
Tablet, Extended Release 500 mg |
|
Tablet, Extended Release 750 mg |
|
Tablet, Extended Release 1,000 mg |
|
Registered Product(s) Information
Clinical and product info
Clinical info | Product Info |
|---|---|
Information under the Indication, Dosage and Contraindication sections are extracted from the relevant Package Insert/Patient Information Leaflet of the product available on HSA Infosearch. For more information, please refer to the product's Package Insert/ Patient Information Leaflet available on HSA Infosearch. The information provided is for informational purposes only, and is not exhaustive. The information provided is not a substitute for professional medical advice. Please consult a qualified healthcare provider for any medical advice. | Information available here are product details as registered with the HSA. As this website is updated monthly, please refer to HSA Infosearch for the most updated product information. |
Oral
AURO METFORMIN 500 FILM-COATED TABLETS 500 MG BP [SIN14509P]
AURO METFORMIN 850 FILM-COATED TABLETS 850 MG BP [SIN14510P]
METSWIFT XR 1000 METFORMIN HYDROCHLORIDE PROLONGED RELEASED TABLETS 1000MG [SIN17333P]*
METSWIFT XR 500 METFORMIN HYDROCHLORIDE PROLONGED RELEASED TABLETS 500MG [SIN17335P]*
METSWIFT XR 750 METFORMIN HYDROCHLORIDE PROLONGED RELEASED TABLETS 750MG [SIN17334P]*
* Clinical information is available for this product.
